<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>OAR@UM Community:</title>
  <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/1640" />
  <subtitle />
  <id>https://www.um.edu.mt/library/oar/handle/123456789/1640</id>
  <updated>2026-04-07T21:55:09Z</updated>
  <dc:date>2026-04-07T21:55:09Z</dc:date>
  <entry>
    <title>TargetMI : unravelling the molecular roots of heart attacks</title>
    <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/144920" />
    <author>
      <name />
    </author>
    <id>https://www.um.edu.mt/library/oar/handle/123456789/144920</id>
    <updated>2026-03-13T14:28:41Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Title: TargetMI : unravelling the molecular roots of heart attacks
Abstract: Cardiovascular disease remains a leading cause of death worldwide, claiming&#xD;
millions of lives each year. Across Europe alone, over 60 million potential years of life&#xD;
are lost annually to cardiovascular deaths. At the University of Malta, Prof. Stephanie&#xD;
Bezzina Wettinger and her team are leading TargetMI, an EU-funded project that&#xD;
aims to examine the molecular pathways behind myocardial infarction, commonly&#xD;
known as heart attacks, and pave the way for targeted prevention and treatment.</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>When one drug isn’t enough : rethinking the treatment of drug resistant chronic myeloid leukaemia</title>
    <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/144918" />
    <author>
      <name />
    </author>
    <id>https://www.um.edu.mt/library/oar/handle/123456789/144918</id>
    <updated>2026-03-13T14:17:09Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Title: When one drug isn’t enough : rethinking the treatment of drug resistant chronic myeloid leukaemia
Abstract: When art meets science, the result&#xD;
can be something extraordinary.&#xD;
For one Maltese researcher,&#xD;
that intersection has become&#xD;
the foundation of a career&#xD;
dedicated to creativity, curiosity,&#xD;
and compassion. From tutoring&#xD;
students and conducting research&#xD;
in the lab, to painting with oils&#xD;
and curating art exhibitions,&#xD;
Antonio Polidano Vella’s life has&#xD;
been a balance of expression&#xD;
and exploration. Looking into his&#xD;
scientific work, particularly his&#xD;
research on drug-resistant Chronic&#xD;
Myeloid Leukaemia, one can see&#xD;
how this could reshape how we&#xD;
think about cancer treatment.</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>The dark side of the web : how does technology facilitate child trafficking?</title>
    <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/144905" />
    <author>
      <name />
    </author>
    <id>https://www.um.edu.mt/library/oar/handle/123456789/144905</id>
    <updated>2026-03-13T11:27:57Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Title: The dark side of the web : how does technology facilitate child trafficking?
Abstract: Child trafficking is one of the most complex crimes worldwide. It thrives in the&#xD;
digital space, where technology is used to recruit, control, and exploit victims. By&#xD;
uncovering how these online networks operate, researchers are discovering new&#xD;
ways to disrupt them. THINK interviewed Dr Aitana Radu, who is working to close&#xD;
the gaps that allow children to fall victim to these schemes.</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Is it good for entrepreneurs to be good?</title>
    <link rel="alternate" href="https://www.um.edu.mt/library/oar/handle/123456789/144901" />
    <author>
      <name />
    </author>
    <id>https://www.um.edu.mt/library/oar/handle/123456789/144901</id>
    <updated>2026-03-13T11:15:00Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Title: Is it good for entrepreneurs to be good?
Abstract: We’re all stressed (welcome to the 21st century, baby).&#xD;
But while you and your colleague may face similar kinds&#xD;
of stress – the same nasty boss, the same ridiculous tight&#xD;
deadlines – the way you cope and how you feel can be&#xD;
remarkably different from person to person. It turns out&#xD;
that the way we cope with stress might just be shaped&#xD;
by the darker and lighter aspects of our personality.&#xD;
Prof. Leonie Baldacchino examines how the dark and&#xD;
light triad traits of entrepreneurs affect how they deal&#xD;
with stress and impact their psychological well-being.</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

